JS
Jalpaben Shivlal Suhagiya
About Jalpaben Shivlal Suhagiya
Data last updated:
Jalpaben Shivlal Suhagiya is a Director at Fadshi Solutions Private Limited (since 2017). The companies operate in Software and Pharma. Fadshi Solutions Private Limited reported revenue of ₹1.01 Cr (FY 2019). Earlier, Jalpaben Shivlal Suhagiya was a Director at Enacare Remedies Private Limited (2021–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Nov 2017 | 2017 | ₹1.01 Cr (FY 2019) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jun 2021 | 2019 | ₹22,560 (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jalpaben Shivlal Suhagiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harikrishna Mistry | 09311277 | Fadshi Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jalpaben Shivlal Suhagiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jalpaben Shivlal Suhagiya
Jalpaben Shivlal Suhagiya currently holds 1 directorship: Fadshi Solutions Private Limited (Director, since 30 Nov 2017, revenue ₹1.01 Cr (FY 2019)).
Jalpaben Shivlal Suhagiya was first appointed on 30 Nov 2017 as Director at Fadshi Solutions Private Limited. The most recent appointment on record is 05 Jun 2021 at Enacare Remedies Private Limited.
Jalpaben Shivlal Suhagiya held 1 earlier board appointment: Enacare Remedies Private Limited (Director, 05 Jun 2021 to 25 Sep 2023).
The current boards of Jalpaben Shivlal Suhagiya's companies include Harikrishna Mistry (Fadshi Solutions Private Limited).